Tuis600196 • SHA
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
Vorige sluiting
¥24,01
Dagwisseling
¥23,75 - ¥24,02
Jaarwisseling
¥20,38 - ¥30,44
Markkapitalisasie
56,81 mjd CNY
Gemiddelde volume
11,61 m
P/V-verhouding
30,35
Dividend-opbrengs
1,13%
Primêre beurs
SHA
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 10,45 mjd | 12,30% |
Bedryfskoste | 4,11 mjd | -4,30% |
Netto inkomste | 785,84 m | 55,43% |
Netto winsgrens | 7,52 | 38,49% |
Wins per aandeel | — | — |
EBITDA | 1,60 mjd | 229,39% |
Effektiewe belastingkoers | 15,05% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,63 mjd | -1,12% |
Totale bates | 115,26 mjd | 4,06% |
Totale aanspreeklikheid | 56,07 mjd | 2,35% |
Totale ekwiteit | 59,19 mjd | — |
Uitstaande aandele | 2,66 mjd | — |
Prys om te bespreek | 1,35 | — |
Opbrengs op bates | 2,03% | — |
Opbrengs op kapitaal | 2,49% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 785,84 m | 55,43% |
Kontant van bedrywe | 1,08 mjd | 65,68% |
Kontant van beleggings | 210,24 m | 122,80% |
Kontant van finansiering | -1,59 mjd | 11,34% |
Netto kontantverandering | -389,75 m | 80,29% |
Beskikbare kontantvloei | -2,97 mjd | 27,05% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
39 309
